The financial relationships that biotech companies, medical device companies and pharmaceutical manufacturers have with customers and vendors are coming under increased government scrutiny. Join us for an informative, case study-focused discussion of the legal compliance issues, including the complex issues around fair market value. We will address anti-kickback, price reporting and industry codes of ethics implications of these arrangements.
Our panel will include lawyers and consultants who regularly advise companies on practical, cost-effective approaches to determining the need for and the fair market value of services and items provided to customers and sought from vendors, including HCPs, research sites, advisory board members, specialty pharmacy providers, wholesalers, specialty distributors, group purchasing organizations and pharmacy benefit managers.
This morning seminar will focus on financial challenges that life science companies face in today’s economy.
William A. Sarraille, Partner
Sidley Austin LLP
- A senior partner in Sidley’s Healthcare Group, Bill Sarraille is a nationally and internationally known figure on coverage, reimbursement and compliance issues for biotech, pharmaceutical and medical device companies. He has been named one of the “Top Ten Practice Attorneys” by Nightengale’s, which rates healthcare attorneys. He is the co-author of four healthcare books on healthcare compliance, coding, clinical research and reimbursement and has served on the editorial boards of another 14 healthcare publications. He is the recipient of three awards from healthcare associations for his work in compliance education.
Andy Bender, President
Polaris Management Partners
- Andy is the founder of Polaris Management Partners. He frequently speaks on topics ranging from state reporting and aggregate spend, publication policies, fair market value, grant and speaker portals. Andy developed Polaris' fair market or fee for services methodology currently adopted by 23 pharmaceutical and medical device companies. In addition, Andy has also developed a fair market value methodology for grant and independent investigator studies payment and a methodology for pricing fees for services provided by PCMs, MCOs and other third parties.
John Boettiger, Principal
Deloitte Financial Advisory Services LLP
- John Boettiger is a principal with Deloitte Financial Advisory Services LLP where he provides clients with integrated transaction and compliance solutions. John has more than 13 years of experience advising major multinational companies on how to create value and manage risk through mergers, acquisitions, joint ventures and other affiliation agreements. Specific to the healthcare industry, John also has experience in analyzing management service agreements and other professional service agreements. John has served as both a testifying and consulting specialist in a number of prior matters. He is a Chartered Financial Analyst, Accredited Senior Appraiser and a Certified Management Consultant.
Bridget Bourgeois, Partner
Ernst & Young
- Bridget Bourgeois is a partner with Ernst & Young’s Transaction Advisory Services Valuation practice. Bridget focuses on valuation analyses for health science companies including pharmaceutical, biotech, medical device, providers managed care and other healthcare companies. Bridget has significant global valuation experience with deal structure analyses and valuations related to business enterprises, equity and intangible assets including branded and generic product lines, drug development and delivery technologies, patents, trademarks, contracts, customer relationships, restrictive covenants and assembled work force valuations for financial reporting and tax purposes.
Thursday, June 4, 2009
8:30 am - 10:30 am
Continental Breakfast at 8 am
To register or for more information, please contact: SFEvents@sidley.com or call 415.772.1240
Applicable California MCLE credit will be provided